DISCOVER
INVESTIGATOR SITE MANAGEMENT
Clinical Trials Mobile Application
We provide innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.
Get a demoOur mission
SOME NUMBERS
Figure: Total R&D/clinical trials pipeline size, by year 2000-2022
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.
CT-SCOUT™ and ToTem4me facilitate the match between the patients and the studies.
50%
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
80%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0.02%
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
2
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Our Solutions
We have customised digital solutions for the different contributors to the clinical research efforts.
CT-SCOUT™
The missing link between sponsor & sites
A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.
Find out more
eISF
The electronic investigator site file
The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements.
Find out more
LATEST NEWSOUR NEWS >
September 2, 2024
17 September 2024 – 11am – 12:30pm EDT Register for this webinar to receive essential updates on the CDISC transition and learn about new regulations and initiatives impacting Trial Master Files (TMF). Don’t miss this opportunity to stay informed about the latest industry standards and practices. Read more and register: https://cdisc.zoom.us/webinar/register/WN_WqNz9_hiRVihH_pe1IEurA#/registration
September 2, 2024
Med City News Innovation is not just a luxury but a necessity in the realm of clinical trials, particularly as we strive to accelerate drug development. Yet, the slow pace of innovation within the U.S. clinical trials system has impeded progress, leaving many stakeholders frustrated. U.S. Food and Drug Administration (FDA) resource limitations cause the […]
September 2, 2024
International Biopharma Data integrity is critical in Biopharma manufacturing yet is often difficult to achieve due to complex regulatory requirements and legacy data management systems, among the many factors. Furthermore, issues such as data accuracy, completeness and security impact product quality, regulatory compliance and ultimately patient safety. Addressing all these challenges demands a multifaceted approach […]